Quote | Freeline Therapeutics Holdings plc (NASDAQ:FRLN)
Last: | $6.48 |
---|---|
Change Percent: | 0.0% |
Open: | $6.49 |
Close: | $6.48 |
High: | $6.49 |
Low: | $6.48 |
Volume: | 5,663 |
Last Trade Date Time: | 02/16/2024 03:00:00 am |
News | Freeline Therapeutics Holdings plc (NASDAQ:FRLN)
Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics today announced the...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Message Board Posts | Freeline Therapeutics Holdings plc (NASDAQ:FRLN)
Subject | By | Source | When |
---|---|---|---|
$FRLN now No 1 on the Barchart Top 10 | Monksdream | investorshub | 07/12/2023 2:43:59 PM |
$FRLN haltedn | Monksdream | investorshub | 07/12/2023 1:37:22 PM |
$FRLN haltedn | Monksdream | investorshub | 07/12/2023 1:37:21 PM |
$THER STOCK NEXT BIG RUN | Jayzp | investorshub | 07/12/2023 1:58:10 AM |
$FRLN Looks pretty positive | Pt3 | investorshub | 07/09/2023 2:04:07 AM |
News, Short Squeeze, Breakout and More Instantly...
Freeline Therapeutics Holdings plc Company Name:
FRLN Stock Symbol:
NASDAQ Market:
Freeline Therapeutics Holdings plc Website:
Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics today announced the...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Please find enclosed the presentation of Frontline plc´s fourth quarter 2023 results to be held on the webcast / conference call 29 February, 2024 at 15:00 CET. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act ...